Yaron Shoham

Original Research

An Open-Label, Proof-of-Concept Study Assessing the Effects of Bromelain-Based Enzymatic Debridement on Biofilm and Microbial Loads in Patients With Venous Leg Ulcers and Diabetic Foot Ulcers

12/20/2023

Robert J. Snyder , MD, PhD, DPM, FACFAS, CWS-P, MBA;

Adam J. Singer ;

Cyaandi R. Dove , DPM;

Yaron Shoham ;

Edward Grant ;

Garth A. James ;

Aya Ben Yaakov ;

Stephen Heisler ;

Elinor deLancey Pulcini ;

Lior Rosenberg ;

Howard Petusevsky ;

This study examines the efficacy of a bromelain-based debridement agent for reduction of biofilm in patients with chronic wounds, including diabetic foot ulcers and venous leg ulcers.

This study examines the efficacy...

12/20/2023

Wounds

Development of a porcine model for chronic wound eschars and evaluation of a Bromelain based enzymatic debriding agent

Background: Advances in the development of novel therapies for chronic wounds has been limited by the lack of validated animal models. In this study, we describe the development of a nove...

Yaron Shoham ;

Adan Singer , MD;

08/19/2021